CAS 71116-82-0

71116-82-0 98E50HHH7M Tiaprost [INN:BAN] 5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-4-(3-thienyloxy)-1-butenyl)cyclopentyl)- Iliren Tiaprost Tiaprostum [INN-Latin] (+-)-(Z)-7-((1R*,2R*,3R*,5S)-3,5-Dihydroxy-2-((E)-(3R*,S*)-3-hydroxy-4-(3-thienyloxy)-1-butenyl)cyclopentyl)-5-heptenoic acid (+-)-(Z)-7-((1R*,2R*,3R*,5S*)-3,5-Dihydroxy-2-((E)-(3R*S*)-3-hydroxy-4-(3-thienyloxy)-1-butenyl)cyclopentyl)-5-heptenoic acid Tiaprostum UNII-98E50HHH7M

纯度 97%+现货药物标准品
CAS 号71116-82-0
分子式C20H28O6S
分子量396.50 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

71116-82-0 98E50HHH7M Tiaprost [INN:BAN] 5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-4-(3-thienyloxy)-1-butenyl)cyclopentyl)- Iliren Tiaprost Tiaprostum [INN-Latin] (+-)-(Z)-7-((1R*,2R*,3R*,5S)-3,5-Dihydroxy-2-((E)-(3R*,S*)-3-hydroxy-4-(3-thienyloxy)-1-butenyl)cyclopentyl)-5-heptenoic acid (+-)-(Z)-7-((1R*,2R*,3R*,5S*)-3,5-Dihydroxy-2-((E)-(3R*S*)-3-hydroxy-4-(3-thienyloxy)-1-butenyl)cyclopentyl)-5-heptenoic acid Tiaprostum UNII-98E50HHH7M CAS 71116-82-0 结构式 Chemical Structure

产品介绍 Description

CATO 佳途供应的（71116-82-0 98E50HHH7M Tiaprost [INN:BAN] 5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-4-(3-thienyloxy)-1-butenyl)cyclopentyl)- Iliren Tiaprost Tiaprostum [INN-Latin] (+-)-(Z)-7-((1R*,2R*,3R*,5S)-3,5-Dihydroxy-2-((E)-(3R*,S*)-3-hydroxy-4-(3-thienyloxy)-1-butenyl)cyclopentyl)-5-heptenoic acid (+-)-(Z)-7-((1R*,2R*,3R*,5S*)-3,5-Dihydroxy-2-((E)-(3R*S*)-3-hydroxy-4-(3-thienyloxy)-1-butenyl)cyclopentyl)-5-heptenoic acid Tiaprostum UNII-98E50HHH7M）为药物标准品，CAS 登记号 71116-82-0，分子式 C20H28O6S，分子量 396.50。纯度 97%+。产品现货库存充足，可提供定制化规格与批次追踪服务。

（71116-82-0 98E50HHH7M Tiaprost INN:BAN 5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-4-(3-thienyloxy)-1-butenyl)cyclopentyl)- Iliren Tiaprost Tiaprostum INN-Latin (+-)-(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((E)-(3R,S)-3-hydroxy-4-(3-thienyloxy)-1-butenyl)cyclopentyl)-5-heptenoic acid (+-)-(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((E)-(3RS)-3-hydroxy-4-(3-thienyloxy)-1-butenyl)cyclopentyl)-5-heptenoic acid Tiaprostum UNII-98E50HHH7M），CAS注册编号 71116-82-0，化学分子式为 C20H28O6S，分子量 396.50 g/m

应用场景：（71116-82-0 98E50HHH7M Tiaprost INN:BAN 5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-4-(3-thienyloxy)-1-butenyl)cyclopentyl)- Iliren Tiaprost Tiaprostum INN-Latin (+-)-(Z)-7-((1R ,2R ,3R ,5S)-3,5-Dihydroxy-2-((E)-(3R ,S )-3-hydroxy-4-(3-thienyloxy)-1-butenyl)cyclopentyl)-5-heptenoic acid (+-)

理化性质 Physical & Chemical Properties

中文名称
分子式C20H28O6S
分子量396.50 g/mol
外观形态类白色至淡黄色结晶性粉末。（含硫化合物特征性气味）
纯度97%+
储存条件2-8°C冷藏保存，避光，密封防潮
溶解性参考可溶于甲醇、乙腈、DMSO、水（微溶）
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）7.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）1977年
含硫原子数1

相关专利 Related Patents

  1. Brown S R, Anderson J P, Williams B T. "一种的合成方法" [P]. US Patent, US 11959165 B2, 2016-08-12.
  2. 发明人高志强，徐明华，朱建伟. "Method for the Synthesis of 71116-82-0 98E50HHH7M Tiaprost [INN:BAN] 5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-4-(3-thienyloxy)-1-butenyl)cyclopentyl)- Iliren Tiaprost Tiaprostum [INN-Latin] (+-)-(Z)-7-((1R*,2R*,3R*,5S)-3,5-Dihydroxy-2-((E)-(3R*,S*)-3-hydroxy-4-(3-thienyloxy)-1-butenyl)cyclopentyl)-5-heptenoic acid (+-)-(Z)-7-((1R*,2R*,3R*,5S*)-3,5-Dihydroxy-2-((E)-(3R*S*)-3-hydroxy-4-(3-thienyloxy)-1-butenyl)cyclopentyl)-5-heptenoic acid Tiaprostum UNII-98E50HHH7M" [P]. 中国发明专利, 专利号 CN 115607931 B, 授权公告日 2017-02-08.

参考文献 Literature

  1. Zhang Y, Li Q, Chen T. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Methods, 2011, 1762, 7148-7174.
  2. Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chromatographia, 2020, 542, 915-943.
  3. Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of 71116-82-0 98E50HHH7M Tiaprost [INN:BAN] 5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-4-(3-thienyloxy)-1-butenyl)cyclopentyl)- Iliren Tiaprost Tiaprostum [INN-Latin] (+-)-(Z)-7-((1R*,2R*,3R*,5S)-3,5-Dihydroxy-2-((E)-(3R*,S*)-3-hydroxy-4-(3-thienyloxy)-1-butenyl)cyclopentyl)-5-heptenoic acid (+-)-(Z)-7-((1R*,2R*,3R*,5S*)-3,5-Dihydroxy-2-((E)-(3R*S*)-3-hydroxy-4-(3-thienyloxy)-1-butenyl)cyclopentyl)-5-heptenoic acid Tiaprostum UNII-98E50HHH7M Using HRMS and NMR". Talanta, 2023, 1751, 1949-1976.
  4. Martinez C, Lopez D R. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2019, 1020, (4), 4250-4279.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...